ASH 2025 Archives - Medical Conferences

Home > Haematology > ASH 2025

Read the full Report (pdf)

American Society of Hematology 2025 6-9 December 2025 Orlando, Florida, USA

Fixed-duration or continuous treatment for CLL?

Presented By

Dr Othman Al-Sawaf , University Hospital of Cologne, Germany

Conference

ASH 2025

Type

News article

22 December 2025 15:59

Dilemma resolved? IV iron use for iron deficiency during acute infections

Presented By

Dr Haris Sohail , Charleston Area Medical Center, WV, USA

Conference

ASH 2025

Type

News article

22 December 2025 15:55

New frontline therapy for AML?

Presented By

Prof. Amir Fathi , Harvard Medical School, MA, USA

Conference

ASH 2025

Type

News article

22 December 2025 15:47

Online First

Leukaemia

New frontline therapy for AML?

Presented By

Prof. Amir Fathi , Harvard Medical School, MA, USA

Conference

ASH 2025

Type

News article

22 December 2025 15:47

New frontline regimen for Ph+ ALL tested in phase 3

Presented By

Prof. Suning Chen , First Affiliated Hospital of Soochow University, China

Conference

ASH 2025

Type

News article

22 December 2025 15:46

Can we use non-TBI conditioning regimens in selected B-cell ALL patients?

Presented By

Prof. Hisham Abdel-Azim , Loma Linda University Cancer Center, CA, USA

Conference

ASH 2025

Type

News article

22 December 2025 15:44

A+ results for ponatinib and blinatumomab in Ph+ ALL

Presented By

Dr Sabina Chiaretti , Sapienza University of Rome, Italy

Conference

ASH 2025

Type

News article

22 December 2025 15:43

Myeloma and Plasma Cell Disorders

First CAR T-cell therapy for AL amyloidosis

Presented By

Dr Heather J. Landau , Memorial Sloan Kettering Cancer Center, NY, USA

Conference

ASH 2025

Type

News article

22 December 2025 15:52

Does earlier cilta-cel treatment improve outcomes in MM?

Presented By

Prof. Luciano Costa , University of Alabama, AL, USA

Conference

ASH 2025

Type

News article

22 December 2025 15:51

Promising data for a novel, innovative bispecific antibody in MM

Presented By

Prof. Jin Lu , Peking University People’s Hospital, China

Conference

ASH 2025

Type

News article

22 December 2025 15:50

MajesTEC results for teclistamab plus daratumumab in MM

Presented By

Prof. María-Victoria Mateos , University of Salamanca, Spain

Conference

ASH 2025

Type

News article

22 December 2025 15:49

First data from in vivo CAR T-cell therapy in MM

Presented By

Prof. Phoebe Joy Ho , University of Sydney, Australia

Conference

ASH 2025

Type

News article

22 December 2025 15:48

Non-Malignant Haematology

Novel foetal haemoglobin inducer for SCD offers hope

Presented By

Dr Sheinei Alan , UVA School of Medicine, Inova Campus, VA, USA

Conference

ASH 2025

Type

News article

22 December 2025 15:56

Dilemma resolved? IV iron use for iron deficiency during acute infections

Presented By

Dr Haris Sohail , Charleston Area Medical Center, WV, USA

Conference

ASH 2025

Type

News article

22 December 2025 15:55

Is exposure to hydroxyurea during pregnancy really that harmful?

Presented By

Dr Anoosha Habibi , University Hospital Henri Mondor, France

Conference

ASH 2025

Type

News article

22 December 2025 15:54

VAYHIT2: Ianalumab shows efficacy in primary ITP

Presented By

Dr Hanny Al-Samkari , Mass General Brigham Cancer Institute, MA, USA

Conference

ASH 2025

Type

News article

22 December 2025 15:53

Lymphoma

Promising new combination therapy for FL

Presented By

Dr Lorenzo Falchi , Memorial Sloan Kettering Cancer Center, NY, USA

Conference

ASH 2025

Type

News article

22 December 2025 16:01

Off-the-shelf CAR T-cell product under investigation in B-cell NHL

Presented By

Dr Jingwei Yu , Tianjin Medical University, China

Conference

ASH 2025

Type

News article

22 December 2025 16:00

Fixed-duration or continuous treatment for CLL?

Presented By

Dr Othman Al-Sawaf , University Hospital of Cologne, Germany

Conference

ASH 2025

Type

News article

22 December 2025 15:59

KITE-363 and KITE-753 fly far in LBCL

Presented By

Prof. Saurabh Dahiya , Stanford University School of Medicine, CA, USA

Conference

ASH 2025

Type

News article

22 December 2025 15:58

Pole-position data for pirtobrutinib in CLL/SLL

Presented By

Prof. Wojciech Jurczak , Maria Sklodowska Curie National Research Institute of Oncology, Poland

Conference

ASH 2025

Type

News article

22 December 2025 15:57

Miscellaneous Topics

Tranexamic acid proves its value in non-cardiac surgery

Presented By

Prof. Brett Houston , University of Manitoba, MB, Canada

Conference

ASH 2025

Type

News article

22 December 2025 16:04

PATHFINDER highlights the importance of treatment sequencing in systemic mastocytosis

Presented By

Dr Andreas Reiter , University Hospital Mannheim, Germany

Conference

ASH 2025

Type

News article

22 December 2025 16:02

Medical Conferences

ASH 2025

Featured articles

Fixed-duration or continuous treatment for CLL?

Dilemma resolved? IV iron use for iron deficiency during acute infections

New frontline therapy for AML?

CONTENTS

Online First

Leukaemia

New frontline therapy for AML?

New frontline regimen for Ph+ ALL tested in phase 3

Can we use non-TBI conditioning regimens in selected B-cell ALL patients?

A+ results for ponatinib and blinatumomab in Ph+ ALL

Myeloma and Plasma Cell Disorders

First CAR T-cell therapy for AL amyloidosis

Does earlier cilta-cel treatment improve outcomes in MM?

Promising data for a novel, innovative bispecific antibody in MM

MajesTEC results for teclistamab plus daratumumab in MM

First data from in vivo CAR T-cell therapy in MM

Non-Malignant Haematology

Novel foetal haemoglobin inducer for SCD offers hope

Dilemma resolved? IV iron use for iron deficiency during acute infections

Is exposure to hydroxyurea during pregnancy really that harmful?

VAYHIT2: Ianalumab shows efficacy in primary ITP

Lymphoma

Promising new combination therapy for FL

Off-the-shelf CAR T-cell product under investigation in B-cell NHL

Fixed-duration or continuous treatment for CLL?

KITE-363 and KITE-753 fly far in LBCL

Pole-position data for pirtobrutinib in CLL/SLL

Miscellaneous Topics

Tranexamic acid proves its value in non-cardiac surgery

PATHFINDER highlights the importance of treatment sequencing in systemic mastocytosis